Structure

Physi-Chem Properties

Molecular Weight:  402.15
Volume:  415.76
LogP:  5.717
LogD:  4.358
LogS:  -6.413
# Rotatable Bonds:  1
TPSA:  65.74
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.521
Synthetic Accessibility Score:  3.765
Fsp3:  0.28
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.628
MDCK Permeability:  1.7330021364614367e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.212

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.017
Plasma Protein Binding (PPB):  96.78743743896484%
Volume Distribution (VD):  0.465
Pgp-substrate:  2.053591728210449%

ADMET: Metabolism

CYP1A2-inhibitor:  0.666
CYP1A2-substrate:  0.569
CYP2C19-inhibitor:  0.897
CYP2C19-substrate:  0.116
CYP2C9-inhibitor:  0.924
CYP2C9-substrate:  0.719
CYP2D6-inhibitor:  0.503
CYP2D6-substrate:  0.211
CYP3A4-inhibitor:  0.682
CYP3A4-substrate:  0.289

ADMET: Excretion

Clearance (CL):  1.85
Half-life (T1/2):  0.073

ADMET: Toxicity

hERG Blockers:  0.062
Human Hepatotoxicity (H-HT):  0.91
Drug-inuced Liver Injury (DILI):  0.968
AMES Toxicity:  0.089
Rat Oral Acute Toxicity:  0.937
Maximum Recommended Daily Dose:  0.538
Skin Sensitization:  0.231
Carcinogencity:  0.839
Eye Corrosion:  0.003
Eye Irritation:  0.016
Respiratory Toxicity:  0.515

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC218300

Natural Product ID:  NPC218300
Common Name*:   YRHQANFINIANSK-ZIAGYGMSSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  YRHQANFINIANSK-ZIAGYGMSSA-N
Standard InCHI:  InChI=1S/C25H22O5/c1-13-14(2)28-22-16-10-11-25(3,4)30-23(16)19-17(15-8-6-5-7-9-15)12-18(26)29-24(19)20(22)21(13)27/h5-14H,1-4H3/t13-,14-/m1/s1
SMILES:  C[C@H]1Oc2c3C=CC(Oc3c3c(c2C(=O)[C@@H]1C)oc(=O)cc3c1ccccc1)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL334946
PubChem CID:   455252
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0001614] Neoflavonoids
        • [CHEMONTID:0003650] Prenylated neoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[15678383]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[16045947]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. stem n.a. PMID[20188156]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. Malaysian n.a. PMID[7506311]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2804 Calophyllum inophyllum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 IC50 = 10000.0 nM PMID[494235]
NPT112 Cell Line MOLT-4 Homo sapiens IC50 = 18000.0 nM PMID[494235]
NPT165 Cell Line HeLa Homo sapiens IC50 = 8300.0 nM PMID[494236]
NPT116 Cell Line HL-60 Homo sapiens IC50 = 35300.0 nM PMID[494236]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC218300 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC282335
0.9643 High Similarity NPC201820
0.9643 High Similarity NPC52576
0.9507 High Similarity NPC59522
0.9448 High Similarity NPC104236
0.9448 High Similarity NPC164205
0.9448 High Similarity NPC19238
0.9362 High Similarity NPC473209
0.9315 High Similarity NPC164299
0.931 High Similarity NPC249942
0.931 High Similarity NPC297886
0.9296 High Similarity NPC472409
0.9291 High Similarity NPC17848
0.9247 High Similarity NPC469933
0.9247 High Similarity NPC161191
0.9247 High Similarity NPC208303
0.9247 High Similarity NPC161864
0.9241 High Similarity NPC57470
0.9225 High Similarity NPC11566
0.922 High Similarity NPC259685
0.922 High Similarity NPC38153
0.9189 High Similarity NPC209142
0.9189 High Similarity NPC312549
0.9184 High Similarity NPC469932
0.9178 High Similarity NPC140120
0.9178 High Similarity NPC180477
0.9172 High Similarity NPC294365
0.9172 High Similarity NPC179970
0.9149 High Similarity NPC161196
0.9122 High Similarity NPC474735
0.9122 High Similarity NPC151973
0.9116 High Similarity NPC321623
0.9116 High Similarity NPC189087
0.911 High Similarity NPC195621
0.911 High Similarity NPC267375
0.911 High Similarity NPC88964
0.911 High Similarity NPC176229
0.911 High Similarity NPC111786
0.911 High Similarity NPC474161
0.911 High Similarity NPC476088
0.911 High Similarity NPC83357
0.911 High Similarity NPC142405
0.911 High Similarity NPC470322
0.911 High Similarity NPC54577
0.911 High Similarity NPC301276
0.911 High Similarity NPC67805
0.911 High Similarity NPC246948
0.911 High Similarity NPC475052
0.911 High Similarity NPC312973
0.911 High Similarity NPC214774
0.911 High Similarity NPC470647
0.911 High Similarity NPC20488
0.9103 High Similarity NPC87609
0.9103 High Similarity NPC112791
0.9103 High Similarity NPC196459
0.9103 High Similarity NPC188632
0.9103 High Similarity NPC470296
0.9103 High Similarity NPC94794
0.9091 High Similarity NPC136095
0.9085 High Similarity NPC157855
0.9085 High Similarity NPC253616
0.9078 High Similarity NPC46869
0.9078 High Similarity NPC99854
0.906 High Similarity NPC290671
0.9048 High Similarity NPC110303
0.9048 High Similarity NPC473077
0.9048 High Similarity NPC283234
0.9048 High Similarity NPC296998
0.9048 High Similarity NPC23728
0.9041 High Similarity NPC469935
0.9041 High Similarity NPC131579
0.9041 High Similarity NPC319752
0.9041 High Similarity NPC131568
0.9041 High Similarity NPC1886
0.9041 High Similarity NPC178627
0.9041 High Similarity NPC469953
0.9041 High Similarity NPC196137
0.9041 High Similarity NPC171656
0.9034 High Similarity NPC36181
0.9034 High Similarity NPC147145
0.9021 High Similarity NPC36414
0.9014 High Similarity NPC268081
0.9 High Similarity NPC469952
0.9 High Similarity NPC469955
0.8986 High Similarity NPC160821
0.8986 High Similarity NPC132592
0.898 High Similarity NPC285630
0.898 High Similarity NPC127059
0.898 High Similarity NPC154217
0.898 High Similarity NPC181388
0.8973 High Similarity NPC223812
0.8973 High Similarity NPC77794
0.8973 High Similarity NPC278249
0.8973 High Similarity NPC478086
0.8973 High Similarity NPC107177
0.8973 High Similarity NPC85162
0.8973 High Similarity NPC125894
0.8973 High Similarity NPC214166
0.8973 High Similarity NPC316816
0.8973 High Similarity NPC81697
0.8966 High Similarity NPC110038
0.8966 High Similarity NPC470555
0.8966 High Similarity NPC22467
0.8966 High Similarity NPC248372
0.8958 High Similarity NPC472515
0.8951 High Similarity NPC103001
0.8947 High Similarity NPC475797
0.8947 High Similarity NPC78554
0.8947 High Similarity NPC109967
0.8947 High Similarity NPC321372
0.8947 High Similarity NPC469936
0.8947 High Similarity NPC474609
0.8947 High Similarity NPC474738
0.8947 High Similarity NPC129053
0.894 High Similarity NPC88983
0.8933 High Similarity NPC78835
0.8933 High Similarity NPC204561
0.8933 High Similarity NPC317715
0.8933 High Similarity NPC316960
0.8933 High Similarity NPC309512
0.8933 High Similarity NPC148945
0.8926 High Similarity NPC5173
0.8926 High Similarity NPC473016
0.8919 High Similarity NPC24673
0.8919 High Similarity NPC177995
0.8919 High Similarity NPC201731
0.8919 High Similarity NPC97716
0.8919 High Similarity NPC104406
0.8919 High Similarity NPC237635
0.8919 High Similarity NPC79469
0.8919 High Similarity NPC474108
0.8919 High Similarity NPC285748
0.8912 High Similarity NPC235217
0.8912 High Similarity NPC473015
0.8912 High Similarity NPC473013
0.8912 High Similarity NPC209040
0.8912 High Similarity NPC473014
0.8904 High Similarity NPC148757
0.8904 High Similarity NPC32739
0.8904 High Similarity NPC265040
0.8904 High Similarity NPC40833
0.8904 High Similarity NPC76372
0.8904 High Similarity NPC296917
0.8904 High Similarity NPC37496
0.8904 High Similarity NPC62840
0.8904 High Similarity NPC306829
0.8904 High Similarity NPC324134
0.8904 High Similarity NPC10937
0.8904 High Similarity NPC76338
0.8904 High Similarity NPC293852
0.8904 High Similarity NPC227579
0.8904 High Similarity NPC328164
0.8904 High Similarity NPC324436
0.8904 High Similarity NPC125855
0.8904 High Similarity NPC223500
0.8904 High Similarity NPC59739
0.8904 High Similarity NPC167624
0.8904 High Similarity NPC107572
0.8904 High Similarity NPC78
0.8904 High Similarity NPC166482
0.8904 High Similarity NPC220998
0.8904 High Similarity NPC299080
0.8904 High Similarity NPC194432
0.8904 High Similarity NPC177354
0.8904 High Similarity NPC66515
0.8904 High Similarity NPC1089
0.8904 High Similarity NPC228504
0.8904 High Similarity NPC214236
0.8904 High Similarity NPC78803
0.8904 High Similarity NPC182852
0.8904 High Similarity NPC64915
0.8904 High Similarity NPC217083
0.8904 High Similarity NPC161506
0.8904 High Similarity NPC166934
0.8897 High Similarity NPC221173
0.8897 High Similarity NPC150522
0.8882 High Similarity NPC108937
0.8882 High Similarity NPC477530
0.8882 High Similarity NPC279218
0.8881 High Similarity NPC254741
0.8873 High Similarity NPC125269
0.8867 High Similarity NPC472633
0.8867 High Similarity NPC29777
0.8867 High Similarity NPC471115
0.8865 High Similarity NPC473655
0.8865 High Similarity NPC101294
0.8859 High Similarity NPC266572
0.8859 High Similarity NPC6511
0.8851 High Similarity NPC470131
0.8851 High Similarity NPC470133
0.8851 High Similarity NPC470134
0.8851 High Similarity NPC109183
0.8851 High Similarity NPC473078
0.8851 High Similarity NPC470132
0.8851 High Similarity NPC228779
0.8844 High Similarity NPC39329
0.8844 High Similarity NPC164980
0.8844 High Similarity NPC143896
0.8844 High Similarity NPC75049
0.8844 High Similarity NPC175504

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC218300 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8881 High Similarity NPD2796 Approved
0.8808 High Similarity NPD7411 Suspended
0.8693 High Similarity NPD7096 Clinical (unspecified phase)
0.8658 High Similarity NPD7410 Clinical (unspecified phase)
0.8627 High Similarity NPD6801 Discontinued
0.8571 High Similarity NPD7819 Suspended
0.8562 High Similarity NPD1550 Clinical (unspecified phase)
0.8562 High Similarity NPD1552 Clinical (unspecified phase)
0.8533 High Similarity NPD4378 Clinical (unspecified phase)
0.8526 High Similarity NPD7075 Discontinued
0.8516 High Similarity NPD8443 Clinical (unspecified phase)
0.8503 High Similarity NPD1549 Phase 2
0.8467 Intermediate Similarity NPD6799 Approved
0.8446 Intermediate Similarity NPD1243 Approved
0.8421 Intermediate Similarity NPD920 Approved
0.84 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8377 Intermediate Similarity NPD4380 Phase 2
0.8345 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.8345 Intermediate Similarity NPD5124 Phase 1
0.8333 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD5494 Approved
0.8301 Intermediate Similarity NPD5403 Approved
0.8299 Intermediate Similarity NPD3748 Approved
0.8289 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD5401 Approved
0.8258 Intermediate Similarity NPD6599 Discontinued
0.82 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD1510 Phase 2
0.8171 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8165 Intermediate Similarity NPD3817 Phase 2
0.8138 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD6832 Phase 2
0.8113 Intermediate Similarity NPD7768 Phase 2
0.8063 Intermediate Similarity NPD3749 Approved
0.8038 Intermediate Similarity NPD1934 Approved
0.8027 Intermediate Similarity NPD1240 Approved
0.8026 Intermediate Similarity NPD3750 Approved
0.8025 Intermediate Similarity NPD6959 Discontinued
0.8012 Intermediate Similarity NPD919 Approved
0.7937 Intermediate Similarity NPD5402 Approved
0.7933 Intermediate Similarity NPD2799 Discontinued
0.7919 Intermediate Similarity NPD1607 Approved
0.7917 Intermediate Similarity NPD3267 Approved
0.7917 Intermediate Similarity NPD3266 Approved
0.7895 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7891 Intermediate Similarity NPD2313 Discontinued
0.7887 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD6166 Phase 2
0.7879 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD5890 Approved
0.7862 Intermediate Similarity NPD5889 Approved
0.7844 Intermediate Similarity NPD5844 Phase 1
0.7844 Intermediate Similarity NPD7054 Approved
0.7815 Intermediate Similarity NPD7033 Discontinued
0.7799 Intermediate Similarity NPD6585 Discontinued
0.7798 Intermediate Similarity NPD7472 Approved
0.7798 Intermediate Similarity NPD7074 Phase 3
0.7778 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD3268 Approved
0.7764 Intermediate Similarity NPD2801 Approved
0.7763 Intermediate Similarity NPD1551 Phase 2
0.7756 Intermediate Similarity NPD1511 Approved
0.7751 Intermediate Similarity NPD6797 Phase 2
0.7707 Intermediate Similarity NPD2533 Approved
0.7707 Intermediate Similarity NPD2534 Approved
0.7707 Intermediate Similarity NPD2532 Approved
0.7706 Intermediate Similarity NPD7251 Discontinued
0.7682 Intermediate Similarity NPD6651 Approved
0.7671 Intermediate Similarity NPD2797 Approved
0.7667 Intermediate Similarity NPD4307 Phase 2
0.7665 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD7808 Phase 3
0.7661 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1512 Approved
0.7651 Intermediate Similarity NPD1296 Phase 2
0.7647 Intermediate Similarity NPD5953 Discontinued
0.7647 Intermediate Similarity NPD2935 Discontinued
0.764 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD7286 Phase 2
0.7619 Intermediate Similarity NPD7473 Discontinued
0.7616 Intermediate Similarity NPD1933 Approved
0.7616 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD2800 Approved
0.7603 Intermediate Similarity NPD3225 Approved
0.7602 Intermediate Similarity NPD6559 Discontinued
0.7597 Intermediate Similarity NPD2346 Discontinued
0.7574 Intermediate Similarity NPD3818 Discontinued
0.7564 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD4628 Phase 3
0.7561 Intermediate Similarity NPD3882 Suspended
0.7558 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD1203 Approved
0.7545 Intermediate Similarity NPD6232 Discontinued
0.7533 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD3226 Approved
0.75 Intermediate Similarity NPD2798 Approved
0.75 Intermediate Similarity NPD1019 Discontinued
0.75 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD1247 Approved
0.7484 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD4308 Phase 3
0.7466 Intermediate Similarity NPD9717 Approved
0.7452 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD4360 Phase 2
0.743 Intermediate Similarity NPD4363 Phase 3
0.7407 Intermediate Similarity NPD7458 Discontinued
0.7407 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD3887 Approved
0.74 Intermediate Similarity NPD4908 Phase 1
0.7397 Intermediate Similarity NPD422 Phase 1
0.7389 Intermediate Similarity NPD2654 Approved
0.7379 Intermediate Similarity NPD17 Approved
0.7368 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD6100 Approved
0.7308 Intermediate Similarity NPD6099 Approved
0.7303 Intermediate Similarity NPD6798 Discontinued
0.7294 Intermediate Similarity NPD3926 Phase 2
0.7289 Intermediate Similarity NPD4288 Approved
0.7285 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1652 Phase 2
0.7268 Intermediate Similarity NPD8285 Discontinued
0.7261 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD5710 Approved
0.7235 Intermediate Similarity NPD7229 Phase 3
0.7235 Intermediate Similarity NPD5711 Approved
0.7233 Intermediate Similarity NPD7003 Approved
0.723 Intermediate Similarity NPD1608 Approved
0.723 Intermediate Similarity NPD3972 Approved
0.7229 Intermediate Similarity NPD8455 Phase 2
0.7229 Intermediate Similarity NPD1465 Phase 2
0.7222 Intermediate Similarity NPD6273 Approved
0.7216 Intermediate Similarity NPD8312 Approved
0.7216 Intermediate Similarity NPD8313 Approved
0.7207 Intermediate Similarity NPD4287 Approved
0.7188 Intermediate Similarity NPD3295 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD5535 Approved
0.7179 Intermediate Similarity NPD7097 Phase 1
0.7162 Intermediate Similarity NPD1610 Phase 2
0.7161 Intermediate Similarity NPD6355 Discontinued
0.7152 Intermediate Similarity NPD2344 Approved
0.7152 Intermediate Similarity NPD2353 Approved
0.7152 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD3787 Discontinued
0.7135 Intermediate Similarity NPD6808 Phase 2
0.7133 Intermediate Similarity NPD1241 Discontinued
0.7123 Intermediate Similarity NPD1548 Phase 1
0.7117 Intermediate Similarity NPD5049 Phase 3
0.7104 Intermediate Similarity NPD4361 Phase 2
0.7104 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD7390 Discontinued
0.709 Intermediate Similarity NPD7584 Approved
0.7076 Intermediate Similarity NPD7199 Phase 2
0.7069 Intermediate Similarity NPD3751 Discontinued
0.7052 Intermediate Similarity NPD2403 Approved
0.7051 Intermediate Similarity NPD4622 Approved
0.7051 Intermediate Similarity NPD4618 Approved
0.7044 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD6002 Phase 3
0.7044 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD6005 Phase 3
0.7044 Intermediate Similarity NPD6004 Phase 3
0.7032 Intermediate Similarity NPD6233 Phase 2
0.7025 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1894 Discontinued
0.7007 Intermediate Similarity NPD9545 Approved
0.7 Intermediate Similarity NPD8434 Phase 2
0.7 Intermediate Similarity NPD8150 Discontinued
0.7 Intermediate Similarity NPD7583 Approved
0.6994 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6987 Remote Similarity NPD3140 Approved
0.6987 Remote Similarity NPD2979 Phase 3
0.6987 Remote Similarity NPD3142 Approved
0.6982 Remote Similarity NPD5353 Approved
0.6981 Remote Similarity NPD4477 Approved
0.6981 Remote Similarity NPD2438 Suspended
0.6981 Remote Similarity NPD5404 Approved
0.6981 Remote Similarity NPD5405 Approved
0.6981 Remote Similarity NPD5406 Approved
0.6981 Remote Similarity NPD4476 Approved
0.6981 Remote Similarity NPD5408 Approved
0.6975 Remote Similarity NPD2354 Approved
0.6975 Remote Similarity NPD2309 Approved
0.6968 Remote Similarity NPD411 Approved
0.6964 Remote Similarity NPD6844 Discontinued
0.6963 Remote Similarity NPD7585 Approved
0.6962 Remote Similarity NPD5688 Approved
0.6962 Remote Similarity NPD5689 Approved
0.6959 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6943 Remote Similarity NPD447 Suspended
0.6943 Remote Similarity NPD7783 Phase 2
0.6943 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6937 Remote Similarity NPD1471 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data